Bruker, Nextval Link Technology Platforms for Drug Screening | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker and Nextval are collaborating on the high-throughput screening of drugs and their metabolites using both companies' platforms, Bruker announced today.

Bruker's ultrafleXtreme MALDI-TOF/TOF mass spectrometer and Nextval's MassInsight technology will be used in the partnership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.